PATENT CLAIM ANALYSIS

Application Number: 15947343
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-01
Patent Classification: ["514", "221000"]

Abstract:
Provided herein are heteroaryl compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. In one embodiment, the compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as CNS disorders and neurological disorders, including, but not limited to, e.g., psychosis, schizophrenia, depression, movement disorders, and Parkinson's disease.

Claim (Index 17):
The compound of  claim 1 , having formula (III-d):

Metadata:
- Claim Count in Document: 100.0
- Percentile: 91.0
- Lexical Diversity: 1.65217
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14399334', '14950834', '15298469', '14884397', '14377673']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8128901013337441
- 35 USC 102 Novelty (BERT): 0.5786970954684737
- Combined Prediction Score: 0.789470800747217
- Mean Citation Score: 390.945736
- Max Citation Score: 549.93964
- Similarity Product: 367.021555139339

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test